home / stock / hbp:cc / hbp:cc news

HBP:CC News and Press, Helix BioPharma Corp.

Stock Information
Company Name: Helix BioPharma Corp.
Stock Symbol: HBP:CC
Market: TSXC
Website: helixbiopharma.com
Menu
HBP:CC HBP:CC Quote HBP:CC Short HBP:CC News HBP:CC Articles HBP:CC Message Board
Get HBP:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
HBP:CC - Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London

(TheNewswire)   Toronto, Ontario – TheNewswire - February 24, 2026 – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical...
HBP:CC - Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases

(TheNewswire) (Toronto, Ontario; February 5, 2026) – TheNewswire - Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage oncolog...

HBP:CC - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025

(TheNewswire) Toronto, Ontario – TheNewswire - 15 December, 2025 – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company&#...

HBP:CC - Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results

(TheNewswire) Toronto, Ontario – TheNewswire - 29 October 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clinic...
HBP:CC - Expected Canadian Company Earnings on Thursday, October 23rd, 2025

FirstService Corporation (FSV:CA) is expected to report $2.26 for Q3 2025 Namibia Critical Metals Inc. (NMI:CA) is expected to report for Q3 2025 Hammond Power Solutions Inc. Class A Subordinate Voting Shares (HPS.A:CA) is expected to report $1.48 for Q3 2025 Winpak Ltd. (WPK:CA) is e...

HBP:CC - Helix BioPharma Responds to Market Activity

(TheNewswire) Toronto, Ontario – TheNewswire - 6 October 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clinica...

HBP:CC - Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025

TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ( "Helix" or the "Company" ), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vincible, is pleased to announce that the Company wil...
HBP:CC - Helix BioPharma Concludes Review, Will Not Proceed with Proposed Equity Draw-Down Subscription Facility with GEM

(TheNewswire) Toronto, Ontario – TheNewswire - 5 September 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clini...

HBP:CC - Helix Biopharma Corp. Announces Publication in Frontiers in Oncology on the Effects of L-DOS47 as Monotherapy in NSCLC

(TheNewswire) Toronto, Ontario – TheNewswire - 13 August 2025 – Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a cl...

HBP:CC - Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Nine Month Period Ended April 30, 2025

(TheNewswire) (Toronto, Ontario) – Helix BioPharma Corp. - TheNewswire - (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinica...
Next 10